URSAPHARM Arzneimittel y CEBINA anuncian una colaboración para readaptar el antihistamínico azelastine para combatir la COVID-19 Ensure that you incorporate all necessary Call information and facts to ensure suitable journalists and likely attendees can certainly achieve you For additional aspects. This consists of your name, e mail deal with,